NASDAQ:ABEO
$2.76
(
-2.13%
)
Friday, 3rd Feb 2023
Abeona Therapeutics Inc. Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $2.49 | $3.20 | Friday, 3rd Feb 2023 ABEO stock ended at $2.76. This is 2.13% less than the trading day before Thursday, 2nd Feb 2023. During the day the stock fluctuated 6.62% from a day low at $2.72 to a day high of $2.90. |
| 90 days | $2.34 | $4.59 | |
| 52 weeks | $2.34 | $9.36 |
Historical Abeona Therapeutics Inc. prices
| Date | Open | High | Low | Close | Volume |
| 2023-02-03 | $2.77 | $2.90 | $2.72 | $2.76 | 158 400 |
| 2023-02-02 | $2.68 | $2.84 | $2.62 | $2.82 | 253 724 |
| 2023-02-01 | $2.55 | $2.65 | $2.52 | $2.65 | 105 218 |
| 2023-01-31 | $2.51 | $2.57 | $2.50 | $2.52 | 195 278 |
| 2023-01-30 | $2.65 | $2.67 | $2.52 | $2.52 | 104 252 |
| 2023-01-27 | $2.62 | $2.71 | $2.61 | $2.65 | 196 806 |
| 2023-01-26 | $2.64 | $2.64 | $2.59 | $2.62 | 184 268 |
| 2023-01-25 | $2.59 | $2.60 | $2.55 | $2.58 | 127 484 |
| 2023-01-24 | $2.58 | $2.65 | $2.58 | $2.60 | 172 714 |
| 2023-01-23 | $2.57 | $2.61 | $2.56 | $2.58 | 90 517 |
| 2023-01-20 | $2.55 | $2.59 | $2.50 | $2.56 | 170 600 |
| 2023-01-19 | $2.60 | $2.60 | $2.49 | $2.54 | 227 125 |
| 2023-01-18 | $2.69 | $2.71 | $2.57 | $2.61 | 232 900 |
| 2023-01-17 | $2.70 | $2.72 | $2.66 | $2.67 | 204 627 |
| 2023-01-13 | $2.68 | $2.75 | $2.64 | $2.65 | 225 462 |
| 2023-01-12 | $2.73 | $2.75 | $2.65 | $2.65 | 205 313 |
| 2023-01-11 | $3.05 | $3.15 | $2.58 | $2.73 | 1 603 600 |
| 2023-01-10 | $3.06 | $3.12 | $3.00 | $3.05 | 191 821 |
| 2023-01-09 | $3.15 | $3.19 | $3.02 | $3.06 | 164 300 |
| 2023-01-06 | $3.11 | $3.15 | $2.99 | $3.10 | 188 720 |
| 2023-01-05 | $3.06 | $3.20 | $2.97 | $3.08 | 233 808 |
| 2023-01-04 | $2.85 | $3.08 | $2.82 | $3.06 | 170 093 |
| 2023-01-03 | $3.09 | $3.15 | $2.83 | $2.86 | 114 713 |
| 2022-12-30 | $2.74 | $3.08 | $2.67 | $3.08 | 241 350 |
| 2022-12-29 | $2.37 | $2.92 | $2.36 | $2.82 | 1 375 542 |
| 2022-12-28 | $2.46 | $2.50 | $2.34 | $2.40 | 158 328 |
| 2022-12-27 | $2.51 | $2.52 | $2.34 | $2.41 | 397 448 |
| 2022-12-23 | $2.61 | $2.64 | $2.46 | $2.51 | 131 308 |
| 2022-12-22 | $2.65 | $2.65 | $2.39 | $2.60 | 262 379 |
| 2022-12-21 | $2.58 | $2.74 | $2.40 | $2.68 | 372 926 |
| 2022-12-20 | $2.52 | $2.75 | $2.47 | $2.60 | 465 749 |
| 2022-12-19 | $2.66 | $2.87 | $2.51 | $2.54 | 347 836 |
| 2022-12-16 | $2.80 | $2.88 | $2.65 | $2.66 | 292 644 |
| 2022-12-15 | $2.95 | $3.01 | $2.80 | $2.85 | 173 857 |
| 2022-12-14 | $3.00 | $3.17 | $2.95 | $2.97 | 205 663 |
| 2022-12-13 | $3.13 | $3.25 | $2.95 | $3.00 | 485 604 |
| 2022-12-12 | $3.23 | $3.23 | $3.08 | $3.10 | 136 641 |
| 2022-12-09 | $3.11 | $3.26 | $3.06 | $3.12 | 153 280 |
| 2022-12-08 | $3.24 | $3.41 | $3.10 | $3.13 | 146 809 |
| 2022-12-07 | $3.44 | $3.50 | $3.18 | $3.24 | 351 875 |
| 2022-12-06 | $3.74 | $3.81 | $3.48 | $3.53 | 320 498 |
| 2022-12-05 | $3.95 | $4.04 | $3.70 | $3.76 | 180 047 |
| 2022-12-02 | $3.81 | $4.08 | $3.75 | $3.99 | 227 292 |
| 2022-12-01 | $3.66 | $3.95 | $3.66 | $3.88 | 231 980 |
| 2022-11-30 | $3.84 | $3.84 | $3.58 | $3.76 | 222 668 |
| 2022-11-29 | $3.85 | $3.95 | $3.80 | $3.81 | 141 006 |
| 2022-11-28 | $3.88 | $4.04 | $3.81 | $3.86 | 259 042 |
| 2022-11-25 | $3.91 | $3.99 | $3.75 | $3.90 | 168 111 |
| 2022-11-23 | $4.09 | $4.18 | $3.88 | $3.94 | 195 905 |
| 2022-11-22 | $4.16 | $4.24 | $4.04 | $4.11 | 157 172 |
About Abeona Therapeutics Inc.
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A; ABO-201 to treat CLN3 disease;... ABEO Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
